INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 211 filers reported holding INSMED INC in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,516,780 | +21.5% | 614,526 | +1.6% | 0.01% | +20.0% |
| Q2 2023 | $12,767,326 | +28.5% | 605,087 | +3.6% | 0.01% | +25.0% |
| Q1 2023 | $9,935,414 | -24.4% | 583,964 | -11.2% | 0.01% | -27.3% |
| Q4 2022 | $13,138,308 | -6.8% | 657,573 | +0.5% | 0.01% | -8.3% |
| Q3 2022 | $14,099,000 | +13.1% | 654,548 | +3.6% | 0.01% | +20.0% |
| Q2 2022 | $12,463,000 | -10.0% | 632,001 | +7.3% | 0.01% | +11.1% |
| Q1 2022 | $13,845,000 | -14.0% | 589,157 | -0.3% | 0.01% | -10.0% |
| Q4 2021 | $16,102,000 | +7.8% | 591,112 | +9.0% | 0.01% | 0.0% |
| Q3 2021 | $14,933,000 | -3.2% | 542,234 | -0.0% | 0.01% | -9.1% |
| Q2 2021 | $15,432,000 | -5.0% | 542,245 | +13.7% | 0.01% | -8.3% |
| Q1 2021 | $16,242,000 | +0.2% | 476,868 | -2.0% | 0.01% | -7.7% |
| Q4 2020 | $16,203,000 | +2.6% | 486,717 | -1.0% | 0.01% | -7.1% |
| Q3 2020 | $15,795,000 | +28.9% | 491,442 | +10.4% | 0.01% | +16.7% |
| Q2 2020 | $12,255,000 | +77.9% | 445,006 | +3.5% | 0.01% | +50.0% |
| Q1 2020 | $6,889,000 | -32.0% | 429,769 | +1.4% | 0.01% | -20.0% |
| Q4 2019 | $10,126,000 | +125.1% | 424,020 | +66.3% | 0.01% | +100.0% |
| Q3 2019 | $4,498,000 | +18.7% | 254,976 | +72.3% | 0.01% | +25.0% |
| Q2 2019 | $3,789,000 | +0.8% | 148,026 | +14.5% | 0.00% | 0.0% |
| Q1 2019 | $3,758,000 | +46.1% | 129,280 | +1.6% | 0.00% | +33.3% |
| Q3 2018 | $2,572,000 | -15.1% | 127,191 | -0.7% | 0.00% | 0.0% |
| Q2 2018 | $3,030,000 | +134.2% | 128,116 | +79.7% | 0.00% | +50.0% |
| Q4 2015 | $1,294,000 | -2.5% | 71,283 | -0.3% | 0.00% | 0.0% |
| Q3 2015 | $1,327,000 | -6.0% | 71,464 | +23.6% | 0.00% | 0.0% |
| Q2 2015 | $1,412,000 | +198.5% | 57,814 | +144.4% | 0.00% | +100.0% |
| Q2 2014 | $473,000 | – | 23,658 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
| Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
| Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
| First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
| Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
| EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
| Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |